Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avricore Health (AVCRF) Revenue (2016 - 2025)

Historic Revenue for Avricore Health (AVCRF) over the last 16 years, with Q3 2025 value amounting to $27372.8.

  • Avricore Health's Revenue fell 9687.56% to $27372.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 6057.47%. This contributed to the annual value of $3.5 million for FY2024, which is 3532.25% up from last year.
  • According to the latest figures from Q3 2025, Avricore Health's Revenue is $27372.8, which was down 9687.56% from $20707.4 recorded in Q2 2025.
  • Avricore Health's 5-year Revenue high stood at $1.0 million for Q4 2024, and its period low was $4018.0 during Q2 2021.
  • Over the past 5 years, Avricore Health's median Revenue value was $407996.4 (recorded in 2023), while the average stood at $413168.7.
  • In the last 5 years, Avricore Health's Revenue surged by 333904.52% in 2022 and then tumbled by 9729.03% in 2025.
  • Avricore Health's Revenue (Quarter) stood at $27917.5 in 2021, then skyrocketed by 2478.78% to $719931.9 in 2022, then skyrocketed by 38.19% to $994857.0 in 2023, then rose by 2.25% to $1.0 million in 2024, then crashed by 97.31% to $27372.8 in 2025.
  • Its Revenue was $27372.8 in Q3 2025, compared to $20707.4 in Q2 2025 and $302504.3 in Q1 2025.